Background The impact of transcatheter edge-to-edge repair (TEER) on the rate and
prognostic impact of hospitalizations in patients with heart failure (HF) and severe secondary …

Up to half of real-world patients with secondary mitral regurgitation who underwent
transcatheter edge-to-edge repair (TEER) do not meet the highly selective COAPT …

Objectives The aim of this study was to assess the impact of age on outcomes in patients
undergoing transcatheter edge-to-edge repair (TEER) from the COAPT (Cardiovascular …

Background Transcatheter mitral valve repair with the MitraClip results in marked clinical
improvement in some but not all patients with secondary mitral regurgitation (MR) and heart …

Background Although mitral valve transcatheter edge-to-edge repair (M-TEER) achieves
symptomatic benefit for a broad spectrum of patients with relevant secondary mitral …

Background: In the randomized COAPT trial (Cardiovascular Outcomes Assessment of the
MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral …

Treatment of symptomatic primary (or degenerative) mitral regurgitation (MR) is well defined,
with surgical repair being the gold standard and transcatheter repair indicated in patients …

Background: The COAPT trial (Cardiovascular Outcomes Assessment of the MitraClip
Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation) …

Abstract Background In the COAPT (Cardiovascular Outcomes Assessment of the MitraClip
Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation) trial …

Abstract Background In the COAPT (Cardiovascular Outcomes Assessment of the MitraClip
Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation) trial …